Skip to content

Intra-operatieve fluorescente beeldvorming alvleesklier tumoren en galwegen.

Intra-operative fluorescent imaging of pancreatic cancer and extra-hepatic bile ducts.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON22113
Enrollment
15
Registered
2012-06-07
Start date
2012-04-20
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pancreatic cancer

Interventions

Standard Whipple procedure will be performed. During surgery, the near-infrared dye Methylene blue (MB) will be injected and the pancreatic carcinoma will be visualized non-invasively using our experi

Sponsors

Leiden University Medical Center (LUMC)
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients diagnosed with pancreatic cancer eligible to undergo a curative resection; 2. Age between 18 and 80 years old.

Exclusion criteria

Exclusion criteria: 1. Patients using SSRI's, SNRI's of TCA's; 2. Allergy to methyleen blue, history of severe renal impairment or G6PD-deficiency; 3. Patient pregnant or lactating.

Design outcomes

Primary

MeasureTime frame
Primary outcome parameter is the number of identified pancreatic tumors.

Secondary

MeasureTime frame
Secundary parameters are the tumor-to-background ratios measured in patients that recieved MB, and the lymfatic drainage pattern of a pancreatic tumor.

Contacts

Public ContactC.J.H. Velde, van de

Leiden University Medical Center (LUMC), Department of Surgical Oncology, P.O. Box 9600

c.j.h.van_de_velde@lumc.nl+31 (0)71 5262309

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)